Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects

X Ruan, A Kubba, A Aguilar… - The European Journal of …, 2017 - Taylor & Francis
Introduction: Polycystic ovary syndrome (PCOS) is a common, heterogeneous disorder
characterised by hyperandrogenic skin symptoms, irregular menstruation and subfertility …

Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects

X Ruan, A Kubba, A Aguilar, AO Mueck - The European Journal of …, 2017 - elibrary.ru
Introduction: Polycystic ovary syndrome (PCOS) is a common, heterogeneous disorder
characterised by hyperandrogenic skin symptoms, irregular menstruation and subfertility …

[引用][C] Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects

X Ruan, A Kubba, A Aguilar… - European Journal …, 2017 - tobias-lib.ub.uni-tuebingen.de
Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical
aspects Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and …

Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects

X Ruan, A Kubba, A Aguilar… - The European journal …, 2017 - pubmed.ncbi.nlm.nih.gov
Introduction Polycystic ovary syndrome (PCOS) is a common, heterogeneous disorder
characterised by hyperandrogenic skin symptoms, irregular menstruation and subfertility …

[引用][C] Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects

X Ruan, A Kubba, A Aguilar… - European Journal of …, 2017 - ub01.uni-tuebingen.de
Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical
aspects Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and …

Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects.

X Ruan, A Kubba, A Aguilar… - The European Journal of …, 2017 - europepmc.org
Objectives To review the present knowledge about PCOS and summarize the role of
CPA/EE in the care of patients suffering from this condition for the practitioner. Methods …

[PDF][PDF] Use of cyproterone acetate/ethinylestradiol in polycystic ovary syndrome: rationale and practical aspects

X Ruan, A Kubba, A Aguilar, AO Mueck - The European Journal of …, 2017 - bjogh.com.cn
Introduction: Polycystic ovary syndrome (PCOS) is a common, heterogeneous disorder
characterised by hyperandrogenic skin symptoms, irregular menstruation and subfertility …